HNI, TTMI, ALNY, IRBT, LLNW Expected To Be Down After Next Earnings Releases
February 7, 2017 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, February 8th 2017 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and earnings reports. HNI Corporation (NYSE:HNI), TTM Technologies Inc. (NASDAQ:TTMI), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), iRobot Corporation (NASDAQ:IRBT), Limelight Networks, Inc. (NASDAQ:LLNW) are all expected to be Down After their earnings are released Wednesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Wednesday:
Symbol Company # of Reports Quarter Release Time HNI HNI Corporation February Earnings Q4 After TTMI TTM Technologies Inc. February Earnings Q4 After ALNY Alnylam Pharmaceuticals, Inc. February Earnings Q4 After IRBT iRobot Corporation February Earnings Q4 After LLNW Limelight Networks, Inc. February Earnings Q4 AfterThis technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
HNI Corporation (NYSE:HNI) - HNI Corporation, together with its subsidiaries, engages in the design, manufacture, and marketing of office furniture and hearth products primarily in the United States, Canada, China, Hong Kong, India, and Taiwan. The company s Office Furniture segment offers a range of metal and wood commercial and home office furniture, which include storage products, desks, credenzas, chairs, tables, bookcases, freestanding office partitions and panel systems, and other related products under the HON, Allsteel, Maxon, Gunlocke, Paoli, HBF, artcobell, Midwest Folding Products, American Desk, basyx by HON, Lamex, and ERGO brands, as well as under private labels. This segment sells its products through independent, local office furniture, and office products dealers; national office product distributors; selling relationships with the end-users; wholesalers; and direct sales to federal, state, and local government offices. The Hearth Products segment provides various gas, electric, wood, and biomass burning fireplaces; inserts; stoves; facings; and accessories, primarily for the home under the Heatilator, Heat & Glo, Majestic, Monessen, Quadra-Fire, Harman Stove, Vermont Castings, and PelPro brand names. This segment markets its products through dealers and distributors, as well as through company-owned distribution and retail outlets. HNI Corporation was founded in 1944 and is headquartered in Muscatine, Iowa..
TTM Technologies Inc. (NASDAQ:TTMI) - TTM Technologies, Inc., together with its subsidiaries, manufactures printed circuit boards (PCBs) worldwide. It provides a range of PCBs and electro-mechanical solutions, including high density interconnect PCBs, conventional PCBs, flexible PCBs, rigid-flex PCBs, custom assemblies and system integration, and IC substrates. It also produces test specialized circuits used in radio-frequency or microwave emission and collection applications; printed circuits with heavy copper cores, and embedded and press-fit coins; PCBs with electrically passive heat sinks; and PCBs with electrically active thermal cores. In addition, the company offers various services, including manufacturability, PCB layout design, simulation and testing, and quick turnaround services. The company s customers include original equipment manufacturers and electronic manufacturing services companies that primarily serve the networking/communications, cellular phone, computing, aerospace and defense, and medical/industrial/instrumentation end markets of the electronics industry. TTM Technologies, Inc. was founded in 1978 and is headquartered in Costa Mesa, California..
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. The company s clinical development programs include Patisiran and Revusiran, which are in Phase III clinical trials for the treatment of transthyretin amyloidosis (ATTR); ALN-TTRsc02, an investigational RNAi therapeutic targeting TTR for the treatment of various forms of ATTR amyloidosis; Fitusiran, an investigational RNAi therapeutic that is in Phase I clinical trial for the treatment of hemophilia and rare bleeding disorders; ALN-CC5, which is in Phase I/II clinical trial for the treatment of complement-mediated diseases; and ALN-AS1 for the treatment of hepatic porphyrias. Its product development programs also include ALN-AAT for the treatment of alpha-1 antitrypsin deficiency-associated liver disease; ALN-PCSsc that is in Phase I clinical trial for hypercholesterolemia; ALN-HBV for the treatment of Hepatitis B virus; ALN-AC3 for the treatment of hypertriglyceridemia; ANGPTL3 for the treatment of hypertriglyceridemia and mixed hyperlipidemia; ALN-AGT for the treatment of hypertensive disorders of pregnancy, including preeclampsia; ALN-GO1 for the treatment of primary hyperoxaluria type 1; ALN-HDV for the treatment of HDV infection; and ALN-PDL for the treatment of chronic liver infections. The company has strategic alliances and collaboration agreements with Ionis Pharmaceuticals, Inc.; Novartis Pharma AG; Novartis/Arrowhead; F. Hoffmann-La Roche Ltd; Roche/Arrowhead; Takeda Pharmaceutical Company Limited; Kyowa Hakko Kirin Co., Ltd.; Cubist Pharmaceuticals, Inc.; Ascletis BioScience Co., Ltd.; Monsanto Company; Sanofi Genzyme; The Medicines Company; Arbutus Biopharma Corporation; Protiva Biotherapeutics, Inc.; The University of British Columbia; and Acuitas Therapeutics Inc. Alnylam Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Cambridge, Massachusetts..
iRobot Corporation (NASDAQ:IRBT) - iRobot Corporation designs, builds, and sells robots for the consumer market worldwide. It offers Roomba robot vacuums for cleaning the floors; iRobot Braava family of mopping robots; iRobot Looj gutter cleaning robots; and iRobot Mirra pool cleaning robots. The company sells its robots through distribution channels including chain stores, national retailers, its online store, and value-added distributors and resellers. iRobot Corporation was founded in 1990 and is based in Bedford, Massachusetts..
Limelight Networks, Inc. (NASDAQ:LLNW) - Limelight Networks, Inc. provides content delivery network services to deliver digital content over the Internet in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers the Orchestrate Platform, a suite of integrated services, which include content delivery services, mobile delivery services, video content management services, performance services for Website and Web application acceleration and security, cloud storage services for various devices, and cloud-based content security services. It also offers professional services and other infrastructure services, such as transit and rack space services. The company serves traditional and emerging media companies operating in the television, music, radio, newspaper, magazine, movie, game, software, and social media industries, as well as enterprises, technology companies, and government entities conducting business online. Limelight Networks, Inc. was founded in 2001 and is headquartered in Tempe, Arizona..
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net